The Federal Trade Commision (FTC) found prescription benefits managers like UnitedHealth's OptumRX have gained $7.3B from ...

CVS Health Corp (CVS) stock saw a decline, ending the day at $51.96 which represents a decrease of $-0.18 or -0.35% from the prior close of $52.14. The stock opened at $51.43 and touched a low of $50.

Shocking revelations from a Federal Trade Commission, or FTC, investigation have exposed how three major prescription benefit managers, or PBMs, ...

The Federal Trade Commission said three top pharmacy suppliers made profits of 7,700 percent on a lifesaving hypertension ...

In past years we have discussed how opioid-related enforcement efforts have remained a top federal and state priority (here, ...

This week's dividend activity included increased payouts from Lakeland Financial (LKFN) and Valero Energy (VLO) as well as ...

As pharmaceutical breakthroughs offer new treatment options, people are paying more attention to the coverage their employers ...

The Federal Trade Commission on Tuesday released an interim report saying that powerful drug middlemen marked up drugs for ...

CVS Health's poor 2024 performance could be turning around in 2025 with a new CEO and potential rebound, despite challenges.

But high medical costs contributed to results that disappointed Wall Street, and the company’s stock fell on the news that it ...

Shares of insurers and pharmacy benefit manager (PBM) companies such as Centene, Elevance Health, Humana and CVS Health are ...

According to the American Diabetes Association, approximately 8.4 million people in the United States need insulin to survive ...